Showing results (101-110 of 301) with videos related to
Sort By:
Pageof 31
Circulation|April 17, 2002
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient miceMichael E Burleigh, Vladimir R Babaev, John A Oates, et al.Circulation Research|September 1, 2007
Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipaseMaria Gustafsson, Malin Levin, Kristina Skålén, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 2011
Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genesVladimir R Babaev, Robert P Runner, Daping Fan, et al.The Journal of Clinical Investigation|December 19, 2002
Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosisMasashi Nishida, Hidehiko Fujinaka, Taiji Matsusaka, et al.International Journal of Molecular Sciences|June 5, 2019
Akt Signaling in Macrophage Polarization, Survival, and AtherosclerosisMacRae F Linton, Javid J Moslehi, Vladimir R BabaevJournal of the American Heart Association|July 2, 2015
Sex-Specific Parental Effects on Offspring Lipid LevelsIrene M Predazzi, Rafal S Sobota, Serena Sanna, et al.Clinical Therapeutics|March 18, 2008
Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapySergio FazioCardiovascular Drugs and Therapy|January 23, 2009
More clinical lessons from the FIELD studySergio FazioNature Medicine|June 1, 2001
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisLiza Makowski, Jeffrey B Boord, Kazuhisa Maeda, et al.Biochemical Pharmacology|June 14, 2005
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null miceMichael E Burleigh, Vladimir R Babaev, Mayur B Patel, et al.Pageof 31